- Home
- MARA vs ARQT Comparison
MARA vs ARQT Comparison
Compare MARA & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MARA | ARQT |
|---|---|---|
| Founded | 2010 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.3B |
| IPO Year | 2010 | 2020 |
Fundamental Metrics
Financial Performance| Metric | MARA | ARQT |
|---|---|---|
| Price | $10.59 | $22.47 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 6 |
| Target Price | $17.85 | ★ $34.00 |
| AVG Volume (30 Days) | ★ 39.9M | 953.1K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 88.79 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $907,093,000.00 | $376,072,000.00 |
| Revenue This Year | N/A | $34.85 |
| Revenue Next Year | $13.31 | $29.39 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 38.20 | ★ 91.34 |
| 52 Week Low | $6.66 | $12.42 |
| 52 Week High | $23.45 | $31.77 |
Technical Indicators
Market Signals| Indicator | MARA | ARQT |
|---|---|---|
| Relative Strength Index (RSI) | 53.56 | 40.89 |
| Support Level | $9.34 | $21.12 |
| Resistance Level | $11.57 | $23.46 |
| Average True Range (ATR) | 0.71 | 0.92 |
| MACD | -0.04 | -0.13 |
| Stochastic Oscillator | 47.04 | 8.53 |
Price Performance
Historical ComparisonAbout MARA Marathon Digital Holdings Inc.
MARA Holdings Inc leverages digital asset computing to support the energy transformation. It secures the blockchain ledger and supports the energy transformation by converting clean, stranded, or underutilized energy into economic value. The company also offers technology solutions to optimize data center operations, including next-generation liquid immersion cooling and firmware for Bitcoin miners. It is focused on computing for, acquiring, and holding digital assets as a long-term investment.
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.